The innovative drug sector on the Hong Kong stock market rose in late trading, with CanSino Biologics (09926.HK) and Sino Biopharmaceutical (01530.HK) gaining more than 6%, WuXi Biologics (02269.HK), Hutchison China MediTech (00013.HK), and Innovent Biologics (01801.HK) rose more than 5%, while WuXi AppTec (02359.HK) gained more than 4%.